SubHero Banner
Text

April 2019

Core topics in this month’s edition include:

  • Eticovo (etanercept-ykro) - new biosimilar approval
  • Letairis (ambrisentan); Proventil HFA (albuterol) - first time generics
  • Lartruvo (olaratumab) - market removal
  • Losartan-containing product recalls

Download PDF

Text